Compare LODE & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LODE | INFU |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1M | 182.4M |
| IPO Year | 2004 | 2005 |
| Metric | LODE | INFU |
|---|---|---|
| Price | $3.09 | $9.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.1M | 113.2K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.31 |
| Revenue | $3,016,163.00 | ★ $143,436,000.00 |
| Revenue This Year | N/A | $2.89 |
| Revenue Next Year | $1,451.44 | $7.66 |
| P/E Ratio | ★ N/A | $31.58 |
| Revenue Growth | ★ 136.66 | 6.36 |
| 52 Week Low | $1.67 | $4.61 |
| 52 Week High | $4.80 | $11.04 |
| Indicator | LODE | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 63.36 |
| Support Level | $3.03 | $9.73 |
| Resistance Level | $3.28 | $9.83 |
| Average True Range (ATR) | 0.19 | 0.50 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 23.89 | 95.80 |
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.